Your session is about to expire
← Back to Search
LITT + Radiation Therapy for Brain Tumor
Study Summary
This trial is testing a new combination of Laser Interstitial Thermal Therapy (LITT) and Hypo-fractionated Radiation Therapy to treat patients with newly diagnosed gliomas.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I've had a full physical and neurological exam in the last 30 days.My cancer has spread to the lower part of my brain or its lining.I am 18 years old or older.I am a woman who can have children and have a recent negative pregnancy test.My scans suggest I have a high-grade brain tumor.I do not have serious heart problems or recent major heart events.I cannot undergo surgery for a stereotactic biopsy or laser ablation.You cannot have an MRI scan.I can do most of my daily activities by myself.My recent brain MRI shows a mass, and I am considered for laser therapy.
- Group 1: LITT with Hypofractionated RT
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there any openings for individuals to take part in this experiment?
"As indicated on clinicaltrials.gov, this medical trial is currently enrolling patients. The initial posting was made on February 20th 2021 and the latest update occurred April 26th 2022."
At which sites is the research study being conducted?
"The 5 sites recruiting patients for this trial include UCH Kaufman Cancer Center in Bel Air, Central Maryland Radiation Oncology in Columbia, and the Maryland Proton Treatment Centre located in Baltimore. Additionally, there are two additional locations that are also participating."
What is the upper boundary for participants in this medical experiment?
"Affirmative. According to the data hosted on clinicaltrials.gov, this medical research is currently recruiting participants since its initial posting in February 20th 2021 and last update on April 26th 2022. 32 patients need to be enrolled from 5 different sites."
Share this study with friends
Copy Link
Messenger